Valentina started working at Fondazione Don Gnocchi this month!

She has received her Master’s degree in Medical and Pharmaceutical Biotechnology at the University of Pavia in April 2020 working on the development of engineered ferritin nanoparticles as drug delivery systems for her experimental thesis.Then, she worked in a company for the processing of COVID-19 swabs and the...

This month, Labion team participated at the Second Symposium of the Italian Society for Extracellular Vesicles (EVIta) in Barga (Lucca, Italy). The symposium brought together italian excellence in the study of extracellular vesicles in the areas of neuroscience, biomarkers, cancer, regenerative medicine, drug delivery, liquid biopsy, immunology and epigenetics.

Dr. Silvia Picciolini presented...

This week LABION team is participating at the Nanomed Europe conference co-organized by the ETPN and Empa, about nanomedicine and translation to market of nanomedical products.

Marzia Bedoni, head of the LABION, is the leader of the Clinical Interface & Social Impact...

Now its time to have a break, relax and enjoy summer!

In the July/August newsletter we sum up the main achievements of the NEVERMIND project, that has now completed its first 18 months. NEVERMIND newsletter_10 The Labion team with the whole NEVERMIND Consortium wishes...

The development of new drugs is nothing but easy. This month the #NEVERMIND newsletter will be centered on CHEMISTRY and its crucial role in the fight against brain disorders! - At UniMI, the laboratory of Prof. Seneci, Partner of the NEVERMIND project, focus their work on synthetic and natural Read more

This month, in the #NEVERMIND  newsletter we will introduce you to two interesting and innovative ways to fight brain diseases:

• a micrometric mesh has been designed by Italian and American researcher to embrace and destry glioblastoma
• natural nanoparticles have been...

This week the LABION team has the great pleasure to participate to the 10th ISEV Annual Meeting. On 18th May, Silvia Piccioli will present the results obtained in collaboration with the Johns Hopkins University School of Medicine about the effect of neutral sphingomyelinase 2 inhibition...

This month, the April newsletter of the #NEVERMIND project is rich of news spanning from educational material to expert insights.

What will you find?

• an educational page on brain tumors was prepared by the NEVERMIND Partner Istituto Clinico Humanitas

• the summary of a recent review published by the LABION team on...

On 12th April 2021, the online magazine Wempower has published the interview by Amina Sofia El-Maghraby to Marzia Bedoni (Head of Labion) and Alice Gualerzi (permanent researcher at Labion).

They talk about the role of women in STEM in Italy and what does it mean to be a female scientist, working in...

The March release of the #NEVERMIND newsletter wants to share with you two stories from the scientific community:

• the lipid shell story to learn when were lipid nanoparticles discovered and how scientists paved the way to the lipid-based COVID-19 vaccines;
• new hope for Alzheimer's patients with a Read more